BROWNSTEIN HYATT FARBER SCHRECK, LLP

Lobbying for ELANCO ANIMAL HEALTH · Animal pharmaceutical company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · Senate · $40,000.00 income · posted Jul 20, 2026

Lobbying activity 2

Pharmacy

Advocacy surrounding the development of pharmaceuticals for animals

Tariff (miscellaneous tariff bills)

Advocacy surrounding tariff exclusions regarding pharmaceuticals for animals

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.